The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships.
PharmGKB collects and disseminates knowledge about the impact of human genetic variation on drug responses; curates and displays primary genotype and phenotype data; annotates gene variants and gene-drug-disease relationships via literature reviews; summarizes important pharmacogenomic genes and drug pathways; and enables consortia examining important questions in pharmacogenomics.
PharmGKB is funded by NIH/NHGRI/NICHD (U24 HG010615).
Company Details
- Founded
- -
- Address
- Stanford, Ca 94305, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pharmgkb.org
- HQ
- Stanford, CA
- Competitors
- Drug Hunter, ACMG - American College of Medical Genetics and Genomics, Pharmacogenomics Global Research Network (PGRN), Clinical Pharmacogenetics Implementation Consortium, PHARMACOGENETICS FOR EVERY NATION INITIATIVE, PharmVar, CANCER GENOMICS CONSORTIUM, Erasmus MC, Precision Medicine, Pharmacy Guild of Australia - NSW Branch.
Pharmgkb Questions
Pharmgkb's website is pharmgkb.org
Pharmgkb's LinkedIn profile is https://www.linkedin.com/company/pharmgkb
Pharmgkb's industry is
Biotechnology Research
Pharmgkb's top competitors are
Drug Hunter,
Acmg - American College Of Medical Genetics And Genomics,
Pharmacogenomics Global Research Network (Pgrn),
Clinical Pharmacogenetics Implementation Consortium,
Pharmacogenetics For Every Nation Initiative,
Pharmvar,
Cancer Genomics Consortium,
Erasmus Mc,
Precision Medicine,
Pharmacy Guild Of Australia - Nsw Branch.
Pharmgkb's categories are Biotechnology Research
Pharmgkb's founding year is 2000
